Literature DB >> 27631790

Appropriate Use of Antiemetics to Prevent Chemotherapy-Induced Nausea and Vomiting.

Devon K Check1, Ethan M Basch2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27631790      PMCID： PMC5558447          DOI： 10.1001/jamaoncol.2016.2616

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  13 in total

Review 1.  Why don't physicians follow clinical practice guidelines? A framework for improvement.

Authors:  M D Cabana; C S Rand; N R Powe; A W Wu; M H Wilson; P A Abboud; H R Rubin
Journal:  JAMA       Date:  1999-10-20       Impact factor: 56.272

Review 2.  Antiemetic guidelines: are they being used?

Authors:  Rolf Kaiser
Journal:  Lancet Oncol       Date:  2005-08       Impact factor: 41.316

3.  American Society of Clinical Oncology 2013 top five list in oncology.

Authors:  Lowell E Schnipper; Gary H Lyman; Douglas W Blayney; J Russell Hoverman; Derek Raghavan; Dana S Wollins; Richard L Schilsky
Journal:  J Clin Oncol       Date:  2013-10-29       Impact factor: 44.544

4.  Assuring the optimal use of serotonin antagonist antiemetics: the process for development and implementation of institutional antiemetic guidelines at Memorial Sloan-Kettering Cancer Center.

Authors:  M J Nolte; R Berkery; B Pizzo; L Baltzer; D Grossano; C D Lucarelli; M G Kris
Journal:  J Clin Oncol       Date:  1998-02       Impact factor: 44.544

Review 5.  Antiemetics: American Society of Clinical Oncology clinical practice guideline update.

Authors:  Ethan Basch; Ann Alexis Prestrud; Paul J Hesketh; Mark G Kris; Petra C Feyer; Mark R Somerfield; Maurice Chesney; Rebecca Anne Clark-Snow; Anne Marie Flaherty; Barbara Freundlich; Gary Morrow; Kamakshi V Rao; Rowena N Schwartz; Gary H Lyman
Journal:  J Clin Oncol       Date:  2011-09-26       Impact factor: 44.544

Review 6.  Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting.

Authors:  Rudolph M Navari; Matti Aapro
Journal:  N Engl J Med       Date:  2016-04-07       Impact factor: 91.245

7.  Investigating racial disparities in use of NK1 receptor antagonists to prevent chemotherapy-induced nausea and vomiting among women with breast cancer.

Authors:  Devon K Check; Katherine E Reeder-Hayes; Ethan M Basch; Leah L Zullig; Morris Weinberger; Stacie B Dusetzina
Journal:  Breast Cancer Res Treat       Date:  2016-03-11       Impact factor: 4.872

8.  Improving the care of patients with regard to chemotherapy-induced nausea and emesis: the effect of feedback to clinicians on adherence to antiemetic prescribing guidelines.

Authors:  Wilson C Mertens; Donald J Higby; David Brown; Regina Parisi; Janice Fitzgerald; Evan M Benjamin; Peter K Lindenauer
Journal:  J Clin Oncol       Date:  2003-04-01       Impact factor: 44.544

9.  Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings.

Authors:  Lorenzo Cohen; Carl A de Moor; Peter Eisenberg; Eileen E Ming; Henry Hu
Journal:  Support Care Cancer       Date:  2006-11-14       Impact factor: 3.603

10.  Adherence to national guidelines for antiemesis prophylaxis in patients undergoing chemotherapy for lung cancer: a population-based study.

Authors:  Daniel R Gomez; Kai-Ping Liao; Sharon Giordano; Hoang Nguyen; Benjamin D Smith; Linda S Elting
Journal:  Cancer       Date:  2012-12-04       Impact factor: 6.860
View more
  1 in total

Review 1.  Exploring the Use of State Medical Cannabis Legislation as a Proxy for Medical Cannabis Use Among Patients Receiving Chemotherapy.

Authors:  Laura E Gressler; Alan P Baltz; Ryan C Costantino; Julia F Slejko; Eberechukwu Onukwugha
Journal:  Curr Treat Options Oncol       Date:  2020-11-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.